Literature DB >> 29191730

Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary Hypertension.

Nir Bar1, Lorin Arie Schwartz1, Simon Biner1, Galit Aviram2, Meirav Ingbir1, Ido Nachmany3, Gilad Margolis1, Ben Sadeh1, Rami Barashi1, Gad Keren1, Yan Topilsky4.   

Abstract

BACKGROUND: The outcome of tricuspid regurgitation (TR) remains unclear because of heterogeneity of etiology and the contradictory results of outcome studies. The aim of this study was to evaluate the clinical outcomes of TR in patients with pulmonary hypertension (PH) and normal left systolic function, stratified to patients with post- or precapillary PH.
METHODS: In patients with no left valvar disease (isolated) functional TR, preserved left systolic function (ejection fraction ≥ 50%), and PH (systolic pulmonary pressure > 50 mm Hg), TR was assessed both qualitatively (grade) and semiquantitatively using the vena contracta method, and retrospective analysis of long-term outcomes was conducted. Patients with severe comorbid diseases were excluded.
RESULTS: The study included 245 patients (age 80.5 years, 37% men, ejection fraction 57%, all with pulmonary systolic pressure > 50 mm Hg). At least moderate to severe TR was diagnosed in 178 patients, and their outcomes were compared with those of 67 patients with the same characteristics and less than mild TR. At least moderate to severe TR was associated with lower survival, independent of all characteristics, right ventricular size or function, comorbidity, or pulmonary pressure (P = .03 for grade and P = .02 for vena contracta). Cox proportional-hazard analysis with interaction terms for TR severity and etiology of PH (post- vs precapillary) showed that the etiology of PH did not affect the association of TR with outcome (P = .90 for the interaction term).
CONCLUSIONS: At least moderate to severe isolated TR is independently associated with excess mortality in patients with preserved systolic function and PH, warranting heightened attention to diagnosis and grading. This is irrespective of etiology (pre- or postcapillary) of PH. Semiquantitative assessment of TR by vena contracta is an independent associate of outcome, superior to standard qualitative assessment.
Copyright © 2017 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure with preserved ejection fraction; Pulmonary artery systolic pressure; Pulmonary hypertension; Tricuspid regurgitation

Mesh:

Year:  2017        PMID: 29191730     DOI: 10.1016/j.echo.2017.09.010

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  8 in total

Review 1.  Tricuspid Valve Percutaneous Therapies.

Authors:  Bhaskar Bhardwaj; Joaquin E Cigarroa; Firas Zahr
Journal:  Curr Cardiol Rep       Date:  2022-06-29       Impact factor: 3.955

Review 2.  Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature.

Authors:  Ahmad Mahdi; Victor Zibara; Kamal Matli; Christy Costanian; Georges Ghanem
Journal:  Open Heart       Date:  2022-06

Review 3.  Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.

Authors:  Lluis Asmarats; Maurizio Taramasso; Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

Review 4.  Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions.

Authors:  Mirjam G Winkel; Nicolas Brugger; Omar K Khalique; Christoph Gräni; Adrian Huber; Thomas Pilgrim; Michael Billinger; Stephan Windecker; Rebecca T Hahn; Fabien Praz
Journal:  Front Cardiovasc Med       Date:  2020-05-05

5.  Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up.

Authors:  Ofir Koren; Henda Darawsha; Ehud Rozner; Daniel Benhamou; Yoav Turgeman
Journal:  BMC Cardiovasc Disord       Date:  2021-04-21       Impact factor: 2.298

Review 6.  Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward.

Authors:  Maciej Kubala; Christian de Chillou; Yohann Bohbot; Patrizio Lancellotti; Maurice Enriquez-Sarano; Christophe Tribouilloy
Journal:  Front Cardiovasc Med       Date:  2022-02-15

7.  Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.

Authors:  Teruhiko Imamura; Nikhil Narang; Gene Kim; Jayant Raikhelkar; Ben Chung; Ann Nguyen; Luise Holzhauser; Daniel Rodgers; Sara Kalantari; Bryan Smith; Takeyoshi Ota; Tae Song; Colleen Juricek; Daniel Burkhoff; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  J Am Heart Assoc       Date:  2020-03-30       Impact factor: 5.501

8.  Renal function in patients with significant tricuspid regurgitation: pathophysiological mechanisms and prognostic implications.

Authors:  S C Butcher; F Fortuni; M F Dietz; E A Prihadi; P van der Bijl; N Ajmone Marsan; J J Bax; V Delgado
Journal:  J Intern Med       Date:  2021-06-10       Impact factor: 8.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.